BU-NOT-SET

CONTACT US
The Recipharm Journey
  • Corporate
Eyes
Insight
Solubility enhancement
  • Drug substance
Man holding liquid container
Fact sheet
Unlocking the key changes to Annex 1
  • Manufacturing
Eyes
Insight
Trends impacting drug dosage forms
  • Drug product
Product line
Insight
Relocation of the production of pharmaceuticals: a strategic endeavour for the European Union
  • Industry trends
Eyes
Insight
Outsourcing solid dose manufacturing trends
  • Manufacturing
Eyes
Insight
Strategic outsourcing of analytical testing solutions to speed up time-to-market
  • Analytical chemistry
Eyes
Insight
Recipharm Cannabinoids
  • Drug product
Eyes
Insight
Explore Recipharm's Full Service Offering
  • Corporate
Recipharm_packaging
Brochure
Insight
  • Drug product
On the pathway to clinic, solubility remains one of the biggest hurdles: CDMO
Insight
  • Manufacturing
US DSCSA: data standardisation
Insight
  • Drug product
Developments in high-throughput screening
Insight
  • Industry trends
CDMOs and innovation: remaining competitive
Insight
  • Industry trends
2018 Forecast: What to watch out for over the coming 12 months in pharma
Insight
  • Manufacturing
Pharmaceutical Manufacturing: one year until the EU FMD
Insight
  • Industry trends
Recipharm’s outlook: The evolution of the CDMO market
Insight
  • Drug product
  • Industry trends
CDMO services: Key drivers of growth
Insight
  • Manufacturing
Preparing for track & trace | pharmaceutical serialization regulations